Trump admin rebate rule to cost $177B, Congressional Budget Office says
The cost comes from insurers raising monthly premium prices on Medicare plan holders.
Budget office: $177B in added costs from Trump drug plan
Budget experts for Congress say the Trump administration's plan to reduce out-of-pocket drug costs for Medicare beneficiaries will cost taxpayers another $177 billion from 2020-2029.
'Death traps': Parents of limo crash victims urge new laws
Parents of people killed in recent limousine crashes in New York state urged legislators Thursday to pass tougher safety regulations to get unsafe vehicles and operators off the road.
Drug company founder, executives convicted of bribe scheme that fueled US opioid crisis
Kapoor, 75, is the highest-ranking pharmaceutical executive convicted in a case tied to a drug crisis that has led to tens of thousands of overdose deaths annually.
Lady Gaga’s mom talks about daughter's mental health struggles
Lady Gaga’s and mother Cynthia Germanotta founded the Born This Way Foundation to shed light on mental health issues facing young people during National Mental Health Awareness month.
Medicare-for-all could increase patient wait times, reduce access to care - CBO
It would also require a substantial uptick in government spending.
Lady Gaga's mom Cynthia Germanotta on the Born This Way Foundation
The Born This Way Foundation
Asian stocks mixed as Fed steers clear of signaling rate cut
Stocks moved broadly higher in early trading on Wall Street Wednesday as large U.S. companies continued to surprise investors with solid profits.
Budget office: Caveats to government-run health system
Congressional budget experts say moving to a government-run health care system like "Medicare for All" would be complicated and potentially disruptive for Americans.
CVS Health CEO rebukes 'Medicare for All' push
The pharmacy chain on Wednesday said higher brand name drug costs drove a nearly 35 percent revenue increase in the first quarter of 2019.
States pursue aggressive drug pricing remedies; PBM, big pharma in crosshairs
Ohio, Pennsylvania, Maryland and others are pushing new proposals and launching investigations into drug costs.
CVS Health beats profit estimates, raises full-year forecast
The company's upbeat outlook could allay some concerns about reimbursement pressures on the sector.
Asia markets mostly closed, Sydney up after new S&P 500 high
U.S. stocks were moving lower early Tuesday, dragged down by big communications companies after Google's parent company, Alphabet, reported a slowdown in revenue growth.
Alphabet and Eli Lilly tumble while WageWorks and GE jump
Stocks that moved substantially or traded heavily on Tuesday: Alphabet Inc., down $97.24 to $1,198.96
Pfizer 1Q profit jumps 9% on higher drug sales, lower costs
Pfizer is reporting a 9% jump in first quarter profit on a strong showing from its biopharmaceutical group.
Philip Morris wins FDA approval to sell tobacco heating device in US
The FDA is still reviewing whether the device is safer than traditional cigarettes.
Keep pets away from gardens to prevent food-borne illness
Animal waste tainting fresh produce is one of the major causes of food-borne ailments.
Merck 1Q net quadruples as cancer drug, vaccine sales soar
Merck is breezing past all expectations for the first quarter with global sales jumping 8 percent to almost $11 billion.
Merck's 1Q profit beats on Keytruda boost
Keytruda has driven much of Merck's recent growth as it maintains its lead as an initial treatment for advanced lung cancer.
Lilly: 1Q Earnings Snapshot
Eli Lilly and Co. (LLY) on Monday reported first-quarter earnings of $4.24 billion.